FDA Adverse Event Injury Summary report: N

POLY-L-LACTIC ACID (POLY-L-LACTIC ACID)

MDR report key: 2042135 · Received March 31, 2011

Report

Report Number
3003496686-2011-17820
Event Type
Injury
Date Received
March 31, 2011
Date of Event
October 10, 2008
Report Date
March 31, 2011
Manufacturer
SANOFIAVENTIA U.S. LLC
Product Code
LMH
PMA / PMN Number
PO30050
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SP
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

INITIAL REPORT: THIS SERIOUS UNSOLICITED REPORT WAS RECEIVED FROM A PHYSICIAN VIA OUR AFFILIATE (B)(4) ON (B)(6) 2011. THIS CASE INVOLVES A (B)(6) FEMALE WHO WAS TREATED WITH POLY-L-LACTIC ACID (SCULPTRA). DURING EACH SESSION POLY-L-LACTIC ACID WAS DILUTED WITH 6 ML OF STERILE WATER PLUS 1 ML OF LIDOCAINE FOR FACIAL REJUVENATION. TREATMENT WAS ADMINISTERED ON: (B)(6) 2008 WITH INJECTIONS TO THE CHEEKS AND MARIONETTE LINES; (B)(6) 2008 INJECTIONS TO THE CHEEKS AND CHEEKBONES; AND (B)(6) 2008 WITH INJECTIONS TO THE CHEEKS AND MARIONETTE LINES. FROM (B)(6) 2008, THIS PT EXPERIENCED TWO NODULES, 2 CM IN SIZE, IN THE RIGHT CHEEKBONE ON THE OUTSIDE OF THE FACE. THE NODULES WERE TREATED WITH LESION SUBCISION AND CORTICOIDS. SURGICAL INTERVENTION WAS NOT REQUIRED AND THE PT RECOVERED ON (B)(6) 2008. DURING (B)(6) 2008, INFLAMMATORY REACTION WAS EXPERIENCED. THE PT RECOVERED SOMETIME THAT SAME MONTH. SINCE (B)(6) 2011, AND INFLAMMATORY REACTION WITH INDURATED NODULES ACROSS THE FACE FROM 2-6 CM WERE NOTED. THE PHYSICIAN DESCRIBED THE ADVERSE EVENT AS VISIBLE NODULES IN ALMOST ALL THE FACE, ESPECIALLY IN THE CHEEK. THE FIRST NODULE APPEARED ON (B)(6) 2008 AND AT THE TIME OF THIS REPORT THERE WERE MORE THAN TEN. THE EVENT IS ONGOING AND HAS LASTED MORE THAN TWO YEARS, BUT HAS CAUSED NO BODILY DYSFUNCTION OR PERMANENT DAMAGE. NO BIOPSY WAS TAKEN. OTHER SUSPECT DRUGS: NONE. SIGNIFICANT/RELEVANT MEDICAL HISTORY INDICATES THIS PT HAS HAD OTHER ESTHETIC TREATMENTS WITH NO SIMILAR EVENTS. RELEVANT CONCOMITANT MEDICATIONS INCLUDE LIDOCAINE. ACTION TAKEN: NOT APPLICABLE. CORRECTIVE TREATMENT: LESION SUBCISION AND CORTICOIDS. OUTCOME: NOT RECOVERED. PHYSICIAN/REPORTER CAUSALITY: NOT INDICATED. A PTC (PRODUCT TECHNICAL COMPLAINT) HAS BEEN INITIATED FOR THIS REPORT: (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 POLY-L-LACTIC ACID (POLY-L-LACTIC ACID) FACIAL FILLER LMH SANOFIAVENTIA U.S. LLC UNK

Patients

Seq Age Sex Outcome Treatment
1 43 YR Other LIDOCAINE (CON.) (B)(6) 2008| PREV MEDS = UNK